Ranibizumab for treating diabetic macular oedema

Technology appraisal guidance
Reference number: TA274
Published: 27 February 2013
Last updated: 26 October 2023

TA274 Macular oedema (diabetic) - ranibizumab: appendix A - GE decision paper - March 2015

TA274 Macular oedema (diabetic) - ranibizumab: appendix A - GE decision paper - March 2015

TA274 Macular oedema (diabetic) - ranibizumab: appendix A - GE decision paper - March 2015
10 April 2015
(67.61 Kb 19 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 07 April 2015